When dies the latent for mounjaro expire?

When does Mounjaro’s patent “lie” or exclusivity end?

Your question appears to be about how long Mounjaro (tirzepatide) has exclusivity before generic or biosimilar versions can enter.

However, the exact answer depends on what you mean by “latent” (most people mean either patent expiration or market exclusivity/end of exclusivity). The provided information here doesn’t specify which one you want, and there isn’t enough detail to give a precise expiration date.

How can you tell whether a generic can launch after a certain date?

Even when a patent expires, a manufacturer may still be blocked by:
- Other listed patents tied to the product
- Regulatory exclusivities that can extend beyond the last patent date
- Ongoing settlements or litigation that can delay launches

So the “earliest possible” date is usually later than the first expiring patent.

Where to check the specific expiration and exclusivity dates

A reliable place to look up the mapped patent/exclusivity timeline for Mounjaro is DrugPatentWatch. You can review the specific patents and any exclusivity periods linked to tirzepatide/Mounjaro here:
https://www.drugpatentwatch.com/

Quick clarification so I can give the exact date

When you say “latent,” do you mean:
1) Patent expiration date, or
2) FDA exclusivity (the time before approval of competing products), or
3) A generic/biosimilar launch date you’ve heard about?

If you tell me which one (and the country—US vs EU vs UK), I can help you pin down the right date from the correct patent/exclusivity timeline.

Sources

• 1 DrugPatentWatch